Skip to content
Menu

ResMed Inc. RMD

Full chart Compare
Set alert

Price alert · RMD

All alert types
235.63 USD -1.25 (-0.53%)

Regular-session close

235.63 0.00 0.00%

After hours · Nov 20, 5:38 PM ET

234.70 Day range 242.43
182.82 52-week range 275.96
YTD
-2.18%
1 year
-3.40%

5D -6.00 (-2.48%)

235240245MonTueWedThuFri235.63
Market cap
33.14B
Revenue (ttm)
5.73B
Profit margin
27.79%
EPS (ttm)
10.98
Shares out
140.66M
P/E ratio
21.46
Forward P/E
17.82
Dividend
2.64 (1.11%)
Ex-dividend date
Nov 12, 2026
YTD return
-2.18%
1-year return
-3.40%
Volume
1.37M
Avg volume
1.31M
Open
237.18
Previous close
236.88
Day's range
234.70 – 242.43
52-week range
182.82 – 275.96
Beta
0.76
Analysts
Buy
Price target
264.33 (+12.2%)
Earnings date
Jan 28, 2027
50-day average
233.49

Key statistics

200-day average
223.51
Enterprise value
32.92B
PEG ratio
1.30
Price / sales
5.78
Price / book
5.57
Payout ratio
22.40%
Revenue growth
5.90%
Free cash flow
1.30B
Total cash
1.01B
Total debt
610.58M
Return on equity
26.40%
Short % of float
7.48%

Fundamental scorecard

23 of 25 checks passed on RMD’s reported financials

ValueGrowthProfitabilityHealthDividend

23of 25 checks passed

  • Value 4 of 5
  • Growth 5 of 5
  • Profitability 5 of 5
  • Financial health 5 of 5
  • Dividend 4 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
RMD Revenue — quarterly 1.41B
RMD Net income — quarterly 418.41M
RMD EPS — quarterly 2.93

Earnings

RMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 28, 2027Dec 30, 20263.03———
Oct 29, 2026Sep 30, 20262.692.91+0.22+8.18%
Aug 6, 2026Jun 30, 20262.892.95+0.06+2.08%
Apr 30, 2026Mar 31, 20262.802.86+0.06+2.14%
Jan 29, 2026Dec 31, 20252.742.81+0.07+2.55%
Oct 30, 2025Sep 30, 20252.512.55+0.04+1.59%

Upgrades / downgrades

RMD analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026Canaccord GenuitydownBuyHold
Oct 30, 2026CitigroupmainNeutralNeutral
Oct 30, 2026RBC CapitalmainOutperformOutperform
Oct 30, 2026Wells FargomainEqual-WeightEqual-Weight
Oct 30, 2026KeybancmainOverweightOverweight
Sep 15, 2026RBC CapitalupSector PerformOutperform

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
resmed.com

News

Your note

Sign in to keep a note on RMD — it syncs with the Stock Master app.

Insider holders

RMD insider holders
InsiderRelationLatest transactionDateShares held
BURT CAROL JDirectorStock Award(Grant)Nov 19, 202518,816
FARRELL MICHAEL JChief Executive OfficerSaleNov 8, 2026481,893
FARRELL MICHAEL J.Chief Executive OfficerSaleOct 6, 2026481,893
FARRELL PETER CRAIGDirectorSaleAug 4, 202652,773
GHOSHAL KAUSHIKOfficerSaleMar 9, 202519,353
GILL HARJITDirectorStock Award(Grant)Nov 19, 202510,940

Institution ownership

RMD institution ownership
Holder% heldSharesValueReported
Blackrock Inc.8.50%11,954,2392.82BSep 29, 2026
Vanguard Capital Management LLC6.72%9,446,0412.23BSep 29, 2026
Vanguard Portfolio Management LLC5.63%7,923,8061.87BSep 29, 2026
State Street Corporation4.63%6,519,2491.54BSep 29, 2026
Geode Capital Management, LLC3.14%4,420,2001.04BSep 29, 2026
Bank Of New York Mellon Corporation2.65%3,729,233878.83MSep 29, 2026

Fund ownership

RMD fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.27%4,605,3091.09BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.67%3,758,092885.63MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.23%3,143,005740.68MJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.37%1,922,453453.05MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Growth Index Fund1.33%1,866,016439.75MJun 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.33%1,874,696441.79MSep 29, 2026